Trial Profile
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis - A Safety and Efficacy Trial in Adult Cystic Fibrosis Subjects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Feb 2024
Price :
$35
*
At a glance
- Drugs Mannitol (Primary)
- Indications Cystic fibrosis
- Focus Registrational; Therapeutic Use
- Sponsors Pharmaxis; Syntara Limited
- 04 Dec 2023 According to a Syntara Limited media release, Pharmaxis has changed its name to Syntara Limited
- 17 Mar 2021 Results presented in a Chiesi Media Release.
- 17 Mar 2021 According to a Chiesi media release, data has been published online in the Journal of Cystic Fibrosis.